Phenomenology and diagnosis of bipolar disorder in children, adolescents, and adults: Complexities and developmental issues
This review addresses the phenomenology of mania/bipolar disorder from a developmental psychopathology perspective and uses cases with longitudinal information to illustrate major points. Beginning with a summary of the phenomenology of bipolar illness as it occurs in adults, the authors identify di...
Gespeichert in:
Veröffentlicht in: | Development and psychopathology 2006-12, Vol.18 (4), p.939-969 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This review addresses the phenomenology of mania/bipolar disorder
from a developmental psychopathology perspective and uses cases with
longitudinal information to illustrate major points. Beginning with a
summary of the phenomenology of bipolar illness as it occurs in adults,
the authors identify diagnostic complexities unique to children and
adolescents. These include the challenges of characterizing elation and
grandiosity; differentiating mania from comorbid symptoms, rages, sequelae
of maltreatment, and typical developmental phenomena; and the unique
manifestations of psychosis. We conclude with the observation that a
significant difference between early and later onset bipolar disorder is
that, in the former, there appears to be a global delay or arrest in the
development of appropriate affect regulation; whereas in adult-onset
bipolar illness, emotion dysregulation generally presents as an
intermittent phenomenon. At this juncture, the study of childhood bipolar
illness would benefit from a developmental psychopathology perspective to
move beyond the level of cross-sectional symptom description to begin to
study individuals over time, focusing on developmental, environmental,
genetic, and neurobiological influences on manifest behavior.This review was supported in part by funding
from NIMH Grant 44801 and grants from Janssen Pharmaceutica and Abbott
Laboratories. |
---|---|
ISSN: | 0954-5794 1469-2198 |
DOI: | 10.1017/S0954579406060470 |